O,O-diacetyl tartaric acid anhydride: RN given refers to (3R-trans)-isomer; used to monitor propranolol in human plasma; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 513914 |
| SCHEMBL ID | 1333553 |
| MeSH ID | M0166056 |
| Synonym |
|---|
| 6283-74-5 |
| nsc-7712 |
| diacetyl-4-tartaric anhydride treated bsa |
| acetic acid 4-acetoxy-2,5-dioxo-tetrahydro-furan-3-yl ester |
| (+)-o,o'-diacetyl-l-tartaric anhydride, 97% |
| AKOS000277852 |
| [(3r,4r)-4-acetyloxy-2,5-dioxooxolan-3-yl] acetate |
| D1911 |
| (+)-diacetyl-l-tartaric anhydride |
| d7xnf76o0k , |
| o,o-diacetyl tartaric acid anhydride |
| unii-d7xnf76o0k |
| einecs 228-502-7 |
| (3r-trans)-dihydro-2,5-dioxofuran-3,4-diyl diacetate |
| nsc 7712 |
| SCHEMBL1333553 |
| (r,r)-2,3-diacetoxy-1,4-butanedioic anhydride |
| (2r,3r)-di-o-acetyltartaric acid anhydride |
| di-o-acetyl-l-tartaric anhydride |
| (3r,4r)-2,5-dioxotetrahydrofuran-3,4-diyl diacetate |
| l-diacetyltartaric anhydride |
| diacetyltartaric anhydride |
| diacetyltartaric acid anhydride |
| 2,5-furandione, 3,4-bis(acetyloxy)dihydro-, (3r,4r)- |
| o,o'-diacetyl-l-tartaric anhydride |
| diacetyltartaric anhydride, l- |
| mfcd00037918 |
| (3r,4r)-4-(acetyloxy)-2,5-dioxooxolan-3-yl acetate |
| (+)-o,o'-diacetyl-l-tartaric anhydride, purum, >=97.0% (nt) |
| AS-68738 |
| F0001-1696 |
| (3r,4r)-2,5-dioxotetrahydrofuran-3,4-diyldiacetate |
| D78416 |
| Q27276225 |
| A868343 |
| 184636-89-3 |
| rel-(3r,4r)-2,5-dioxotetrahydrofuran-3,4-diyl diacetate |
| (+)-o,o'-diacetyl-l-tartaric anhydride |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||